Correlation Between Denali Therapeutics and Kintara Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Denali Therapeutics and Kintara Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Denali Therapeutics and Kintara Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Denali Therapeutics and Kintara Therapeutics, you can compare the effects of market volatilities on Denali Therapeutics and Kintara Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Denali Therapeutics with a short position of Kintara Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Denali Therapeutics and Kintara Therapeutics.

Diversification Opportunities for Denali Therapeutics and Kintara Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Denali and Kintara is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and Kintara Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kintara Therapeutics and Denali Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Denali Therapeutics are associated (or correlated) with Kintara Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kintara Therapeutics has no effect on the direction of Denali Therapeutics i.e., Denali Therapeutics and Kintara Therapeutics go up and down completely randomly.

Pair Corralation between Denali Therapeutics and Kintara Therapeutics

If you would invest  2,509  in Denali Therapeutics on January 17, 2024 and sell it today you would lose (725.00) from holding Denali Therapeutics or give up 28.9% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.2%
ValuesDaily Returns

Denali Therapeutics  vs.  Kintara Therapeutics

 Performance 
       Timeline  
Denali Therapeutics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Denali Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak essential indicators, Denali Therapeutics demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Kintara Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kintara Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Kintara Therapeutics is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.

Denali Therapeutics and Kintara Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Denali Therapeutics and Kintara Therapeutics

The main advantage of trading using opposite Denali Therapeutics and Kintara Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Denali Therapeutics position performs unexpectedly, Kintara Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kintara Therapeutics will offset losses from the drop in Kintara Therapeutics' long position.
The idea behind Denali Therapeutics and Kintara Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

AI Investment Finder
Use AI to screen and filter profitable investment opportunities
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Stocks Directory
Find actively traded stocks across global markets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.